Association of PIK3CA mutations (mut) with immune engagement and clinical benefit from immunotherapy in microsatellite stable (MSS) colorectal cancer (CRC) patients (pts).

Nusrat, M; Roszik, J; Katkhuda, R; Menter, D; Raghav, KPS; Morris, VK; Sharma, P; Allison, JP; Blando, JM; Maru, DM; Lizee, G; Janku, F; Overman, MJ; Kopetz, S

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):